Kymera Therapeutics, Inc. · NASDAQ:KYMR

Biotechnology Value Fund II LP sold 1,630,658 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jun 26, 2026 · Filed Jun 26, 2026

On Jun 26, 2026, Biotechnology Value Fund II LP (Director, See Remarks and Footnotes) sold 1,630,658 Kymera Therapeutics, Inc. shares at US$106.50 for US$174M, leaving 78,787 shares. Filed Jun 26, 2026 (Form 4).

Sold
1,630,658 shares
Price
US$106.50
Value
US$174M
Holding after
78,787 shares (held indirectly)
Trading plan
No
Role
Director, See Remarks and Footnotes

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Common Stock, $0.0001 par valueSale837,914US$106.501,960,881Direct
Jun 26, 2026Common Stock, $0.0001 par valueSale627,597US$106.501,592,261Direct
Jun 26, 2026Common Stock, $0.0001 par valueSale113,289US$106.50240,123Direct
Jun 26, 2026Common Stock, $0.0001 par valueSale51,858US$106.5078,787Indirect

Source

View original at SEC

Related